Our leadership team

We are excited to announce that our IVDR-CE marked MosaiQ AiPlex® Celiac Disease (CD) system is now available in the EU market and other geographies that recognize the CE mark (pending local registration in some countries). Celiac Disease is a

AliveDx is dedicated to expanding its reach and presence across diverse regions, with the goal of delivering both clinical and economical value to clinicians by reducing the time to diagnosis for patients suffering from autoimmune and allergy diseases.  We are

We are delighted to speak at the upcoming International Friday Meeting on Friday, 6 December 2024 at 6:30AM CET. The International Friday Meeting is a monthly meeting, held on the first Friday of the month, hosted by Pr. Yehuda Shoenfeld.

AliveDx Suisse S.A. and Medikonia Limited have signed a distribution agreement, which will enable Medikonia to distribute the MosaiQ® solution in Hong Kong and Macau. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence

We are proud to announce that we have become a member of BIVDA, the UK’s leading IVD industry association. BIVDA is the national industry association for manufacturers and distributors of medical diagnostic tests in the UK, representing 97% of the

AliveDx Suisse S.A. and Bio-State Inc. have signed a distribution agreement, which will enable Bio-State Inc. to distribute the MosaiQ® solution in India. The distribution agreement takes effect immediately. This strategic partnership with an important partner in India reaffirms AliveDx’s